CULLEN INVESTMENT GROUP, LTD.

Position in LLY — ELI LILLY & Co

CIK 797203 LAFAYETTE, LA

Position in LLY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$13,969,762

+$3,118,316 QoQ

Shares Held

11,647

-1.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.79%

of 13F equity value

Holder Rank

#1,070

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CULLEN INVESTMENT GROUP, LTD. holds $51,757,200 across 9 Drug Manufacturers - General names. LLY ranks #2 (27.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	110,982	$14,261,187
2	LLY	ELI LILLY & Co This page	11,647	$13,969,762
3	NVS	Novartis AG	55,534	$8,703,288
4	JNJ	Johnson & Johnson	24,881	$6,319,027
5	ABBV	AbbVie Inc.	12,865	$3,237,348
6	AMGN	Amgen Inc	7,730	$2,799,187
7	GILD	Gilead Sciences, Inc.	12,730	$1,608,308
8	NVO	Novo Nordisk A S	10,000	$479,400

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,969,762	11,647	-1.3%	Shares	Sole	2026-07-09
2026-03-31	$10,851,446	11,798	-2.1%	Shares	Sole	2026-04-09
2025-12-31	$12,947,745	12,048	-2.1%	Shares	Sole	2026-01-12
2025-09-30	$9,385,663	12,301	-1.6%	Shares	Sole	2025-10-07
2025-06-30	$9,745,684	12,502	-1.3%	Shares	Sole	2025-07-01
2025-03-31	$10,466,757	12,673	-1.1%	Shares	Sole	2025-04-01
2024-12-31	$9,893,180	12,815	+0.4%	Shares	Sole	2025-01-13
2024-09-30	$11,306,366	12,762	-1.0%	Shares	Sole	2024-10-04
2024-06-30	$11,670,348	12,890	-5.0%	Shares	Sole	2024-07-01
2024-03-31	$10,559,251	13,573	-0.6%	Shares	Sole	2024-04-04
2023-12-31	$7,962,104	13,659	—	Shares	Sole	2024-01-30
No filing history on record for this holder in this stock.